Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

More News From fortuneweek.com

Gains by banks, technology firms lead US stocks higher

Oct 20, 2017

Technology companies and banks led U.S. stocks higher in late-afternoon trading Friday, placing the market on course to extend its gains for the week. Investors cheered a crop of strong company earnings. They also drew encouragement from the Senate's passage of a budget bill, a move expected to ease the path for the White House's tax cut proposal. Consumer products companies lagged the most. KEEPING SCORE: The Standard & Poor's 500 index rose 11 points, or 0.5 percent, to 2,573 as of 3:10 p.m. Eastern time. The Dow Jones industrial average gained 130 points, or 0.6 percent, to 23,293. The...

Rio Olympic head leaves prison; will face corruption charges

Oct 20, 2017

RIO DE JANEIRO — Carlos Nuzman, who headed last year's Rio de Janeiro Olympics, left prison Friday after his arrest two weeks ago on eventual charges that he arranged bribes to land the games for Brazil. The 75-year-old Brazilian is to stand trial for money laundering, tax evasion, and racketeering, though it's unclear how long that will take under Brazil's slow-moving justice system. Brazilian and French authorities say Nuzman helped direct about $2 million to Papa Massata Diack to win votes to land the 2016 Olympics. In the 2009 vote by the International Olympic Committee, Lamine Diack — Papa Massata...

Killer of Navajo Nation girl set to get life prison sentence

Oct 20, 2017

ALBUQUERQUE, N.M. — A man who pleaded guilty to the murder and sexual assault of an 11-year-old girl on the largest American Indian reservation is expected to receive a life prison sentence. Tom Begaye was scheduled Friday to receive the sentence under a plea agreement for the May 2016 killing. The case prompted calls to expand the Amber Alert system and the death penalty to U.S. tribal communities. Authorities have said Begaye lured Ashlynne Mike and her brother into his van in May 2016 before he killed the girl and let the boy escape. Ashlynne was reported missing but an...

AP-NORC poll: Vegas shooting doesn't change opinions on guns

Oct 20, 2017

ATLANTA — A new poll finds that the slaying of five dozen people at a Las Vegas music festival did little to change American opinion about gun laws. In the survey from The Associated Press-NORC Center for Public Affairs Research, 61 percent said the country's gun laws should be tougher, while 27 percent would rather see them remain the same and 11 percent want them to be less strict. That's similar to the results of an AP-GfK poll in July 2016. The new poll found the country divided much more evenly on whether restricting firearms would reduce the number of...

Parole board rejects condemned Ohio inmate's mercy request

Oct 20, 2017

COLUMBUS, Ohio — The Ohio Parole Board on Friday rejected a request for mercy from a condemned inmate who argues he had such a bad childhood and is in such poor health that he should be spared from execution next month. The board's 11-1 decision came in the case of Alva Campbell, set to die by lethal injection on Nov. 15 for killing a teen during a 1997 carjacking. The slaying came five years after he was paroled on a different murder charge. Republican Gov. John Kasich has the final say. The board concluded that Campbell's upbringing and childhood experiences...